Belle Health is a telehealth company founded in 2017 by Chase Jardine, headquartered in Draper, Utah, offering compounded GLP-1 medications including semaglutide and tirzepatide through an online-only provider model with no in-person visits required at any stage of the program.
The company holds a 4.3 out of 5 Trustpilot rating from 343 reviews and an 84 out of 100 AllyRx editorial score. Semaglutide at $119 per month flat rate is the core offering. Clinical trials show semaglutide produces 12-15% body weight reduction over 68 weeks. Belle’s compounded version delivers the same active ingredient at roughly 90% lower cost than brand Ozempic.
This review covers how the five-step program works, what users report on shipping speed and side effects, how Belle compares to Fridays, Ro, and Mochi Health on price and support depth, and what the February 2026 FDA warning letter means for buyers evaluating the program today.
What Is Belle Health?
Belle Health is a telehealth company headquartered in Draper, Utah, founded in 2017 by Chase Jardine and operating via joinbelle.com. The platform connects adults seeking weight loss support with licensed providers entirely online. No in-person appointments required.
Here’s the thing: the company’s primary offering centers on compounded GLP-1 medications. Semaglutide and tirzepatide are both available through a provider-guided model that routes prescriptions to named pharmacy partners for fulfillment.
Belle Health claims more than 30,000 customers have used its programs. The company ships to all 50 states, making it accessible to a broad national audience regardless of local healthcare access.
Is Belle Health a Legitimate Company?
Yes. Belle Health is a registered LLC in Draper, Utah, with a Better Business Bureau A+ rating, though the company is not BBB accredited. The BBB file was opened in January 2025. The company has operated since 2017.
But here’s the part most people miss. In February 2026, the FDA issued a warning letter to Belle Health for misleading website labeling. The letter cited Belle’s website for implying Belle was the compounder of its semaglutide and tirzepatide products when in fact it’s not. The company uses third-party pharmacy partners for compounding.
On Trustpilot, Belle Health holds a 4.3 out of 5 rating based on 343 reviews. Approximately 75% of reviewers awarded 5 stars. That’s a solid rating for a telehealth weight loss company where expectations run high.
What Does Belle Health Offer?
Belle Health offers compounded semaglutide and tirzepatide, both GLP-1 class medications, through a provider-guided telehealth model that includes prescription management and pharmacy fulfillment. No office visit is needed at any stage.
Medications Available:
- Compounded semaglutide at $119 per month flat rate
- Compounded tirzepatide (pricing separate)
The support model relies on asynchronous messaging with a care team. Users can send questions and receive responses, though the platform offers fewer live check-ins compared to coaching-focused competitors. Dose adjustments are handled through this messaging channel.
And here’s the best part: semaglutide stays at $119 per month regardless of dose. The price doesn’t increase as titration progresses. Belle charges no membership fees and typically offers free overnight shipping after approval.
How Does Belle Health Work?
Belle Health operates on a five-step process: online screening, provider review, pharmacy fulfillment, shipping, and self-administration. Each step is handled remotely. No in-person requirement at any point.
How the process works:
- Complete an online health questionnaire at joinbelle.com.
- A licensed provider reviews the intake form asynchronously.
- Prescription is routed to a named compounding pharmacy partner.
- Medication is shipped, often overnight after approval.
- Patient self-administers subcutaneous injection at home.
The onboarding platform saves progress on desktop. Mobile users have reported that leaving the browser, even briefly, can reset the current step. Belle updated its onboarding process after a September 2025 review flagged these issues, so it’s worth trying on desktop if you hit friction.
Bottom line: ongoing support is asynchronous. It suits independent users well. But if you want live check-ins or structured coaching, the model will feel light compared to competitors like Mochi Health or Fridays.
What Is the Online Screening Process?
Belle Health’s screening consists of an online health questionnaire completed at joinbelle.com, reviewed asynchronously by a licensed provider with no in-person visit required at any stage. The intake form covers medical history, current medications, and weight loss goals.
Here’s something worth knowing: Belle Health doesn’t publicly state a minimum BMI requirement. That’s different from some GLP-1 telehealth providers that restrict access to users above a specific BMI threshold. The open eligibility policy makes Belle more accessible for a wider range of candidates.
The approval-to-delivery window? It runs 7-10 business days in standard cases. Some reviewers report receiving medications within 3 days of provider approval. The variation depends on pharmacy workload and shipping destination.
How Does Pharmacy Fulfillment Work?
Belle Health routes prescriptions to named third-party pharmacy partners for compounding and fulfillment, a fact the FDA confirmed in its February 2026 warning letter clarifying that Belle is not the compounder of its products.
In fact, shipping after approval is frequently overnight and often at no extra cost. Multiple Trustpilot reviewers report medications arriving within 3 days of provider sign-off. For compounded GLP-1 medications that require cold chain handling, fast delivery isn’t just convenient. It protects potency.
Compounded semaglutide and tirzepatide require proper storage once received. Cold chain integrity during shipping is a practical concern with all injectable GLP-1 products. Reviewers specifically cite fast delivery as the factor that preserves medication quality on arrival.
What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1, increasing insulin production, slowing gastric emptying, and suppressing appetite to drive weight loss. The FDA approved it under the brand names Ozempic and Wegovy.
Think of it this way: semaglutide doesn’t just suppress appetite. It changes how quickly food moves through your digestive system, which keeps you feeling full longer and reduces caloric intake automatically. Clinical trials showed average weight loss of 12-15% of body weight over 68 weeks.
Compounded semaglutide contains the same active ingredient as the brand versions. The compounded form isn’t FDA-approved as a finished drug product, but it’s dispensed legally by licensed 503A and 503B compounding pharmacies. Belle Health sources its compounded semaglutide through named partners of this type.
Is Compounded Semaglutide the Same as Ozempic?
Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy but isn’t the same product, as the compounded version hasn’t been reviewed or approved by the FDA as a finished drug.
Here’s why that matters. Belle Health receives its compounded semaglutide from third-party pharmacy partners, not from Novo Nordisk, the manufacturer of Ozempic. The FDA’s February 2026 warning letter specifically addressed Belle’s website language for implying otherwise. The active ingredient is chemically equivalent, but the manufacturing source and regulatory oversight differ.
Cost comparison:
| Option | Monthly Cost (USD) | FDA Approved as Finished Drug? |
|---|---|---|
| Brand Ozempic | $900-$1,300 | Yes |
| Brand Wegovy | $1,300-$1,600 | Yes |
| Belle Health compounded semaglutide | $119 | No (compounded) |
What Is Tirzepatide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist, the first of its kind, that targets visceral fat stored around the midsection, heart, and arteries through a two-receptor mechanism that outperforms single-receptor GLP-1 drugs in clinical trials.
And this is where it gets interesting. Tirzepatide works on two receptors simultaneously: GIP and GLP-1. Semaglutide only hits GLP-1. That dual action is why clinical results are stronger for tirzepatide in head-to-head trials. Brand names include Mounjaro (diabetes) and Zepbound (weight loss), both from Eli Lilly.
The SURMOUNT-5 trial reported tirzepatide users lost approximately 20% of body weight compared to 14% for semaglutide users over 72 weeks. That’s not a small difference. The dual mechanism accounts for most of it, and it’s why tirzepatide is increasingly the first-choice option for people who can access it.
What Do Belle Health Reviews Say?
Belle Health holds a 4.3 out of 5 rating on Trustpilot from 343 reviews and an AllyRx editorial score of 84 out of 100, placing it among the stronger-rated telehealth GLP-1 providers in the compounded medication segment.
Approximately 75% of Trustpilot reviewers gave 5 stars. That’s a strong distribution for this category. Telehealth weight loss companies tend to produce polarized review profiles because expectations are high and experiences vary widely. Belle’s rating holds up.
The AllyRx user rating of 4.2 from 5 expert reviews reinforces the Trustpilot picture. Reviewers skew toward buyers who chose Belle primarily for price and independence. Not for coaching depth or clinical oversight.
What Are the Positive Experiences?
Shipping speed is the most consistently praised aspect of Belle Health, with multiple Trustpilot reviewers reporting medications arriving within 3 days of provider approval and comments like ‘meds arrived in just a few days’ and ‘shipments come super fast’ appearing frequently.
Customer service responsiveness draws repeated praise. Reviewers note questions are answered promptly. One reviewer specifically cited the care team for pacing dose escalation based on patient tolerance, not a rigid schedule. That approach reduces nausea-driven dropout. People stay on the program longer when titration is personalized.
Affordability rounds out the top three positives. Several reviewers describe Belle Health as ‘the most affordable option’ they evaluated. At $119 per month, Belle’s flat-rate semaglutide pricing is consistently the deciding factor over competitors.
What Are the Common Complaints?
The most common complaint involves the 7-10 business day window from provider approval to medication delivery, which surprises users expecting the same speed they read about in positive reviews. The fast shipping those reviewers mentioned starts after approval. The approval itself takes time.
Mobile onboarding friction is the second pattern. Reviewer Sabina, who tests GLP-1 providers monthly, reported that leaving the browser on mobile, even briefly to look up a credit card number, reset the form to the start of that step. Belle updated its onboarding post-September 2025. If you hit this, switch to desktop.
Limited ongoing support is the third complaint. Belle’s async messaging model suits independent users but draws criticism from those wanting live check-ins or structured coaching. Fridays and Mochi Health include group coaching. Belle doesn’t.
Pros:
- Flat $119/month semaglutide pricing with no dose-based increases
- No membership fees and named pharmacy partners
- Often free overnight shipping after provider approval
- 4.3/5 Trustpilot rating from 343 reviews
- Responsive care team that allows patient-paced titration
Cons:
- 7-10 business day approval-to-delivery window in standard cases
- Mobile onboarding form can reset when switching apps
- Lighter on live check-ins vs coaching-focused competitors
- FDA warning letter issued February 2026 for misleading labeling
What Are the Side Effects?
GLP-1 medications commonly cause nausea, injection site reactions, and gastrointestinal discomfort, with symptoms typically peaking during initial dosing and dose escalation periods before subsiding as the body adjusts.
Common side effects:
- Nausea (most frequent, especially weeks 1-2 and during dose escalation)
- Reduced appetite
- Constipation or diarrhea
- Injection site redness or bruising
- Fatigue during the adjustment period
Here’s why nausea happens. Semaglutide and tirzepatide slow gastric emptying. That’s the mechanism that keeps you feeling full, but it also causes digestive discomfort in a significant portion of users. Symptoms are worst in the first 2-4 weeks and during each dose increase.
Serious risks are worth knowing upfront. GLP-1 medications are contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. Pancreatitis is an uncommon but documented risk. These contraindications apply to the entire drug class, not just Belle’s compounded version.
What Side Effects Do Users Report?
Belle Health semaglutide users most commonly report nausea and reduced appetite in the first 1-2 weeks of use, with symptoms typically improving as the body adjusts to the starting dose before any escalation occurs.
Dose escalation triggers the most pronounced side effects. Belle’s care team is noted in Trustpilot reviews for allowing patient-paced titration, slowing dose increases when a user reports difficult symptoms. That approach reduces dropout due to intolerance. It’s one of the program’s practical strengths.
Injection site reactions are common across all injectable GLP-1s, not just Belle’s. Redness, mild swelling, or bruising at the subcutaneous injection site are typical. Rotating injection sites and using the correct needle angle reduce local reactions significantly.
Who Should Avoid Belle Health?
Individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome must not use GLP-1 medications including those obtained through Belle Health, as this is a hard contraindication for the entire drug class. Pregnancy and active pancreatitis are also contraindications.
Buyers who want frequent live check-ins, group coaching, or structured accountability programs should look elsewhere. Belle’s async model serves independent users, but it doesn’t replicate the coaching depth of Fridays, Mochi Health, or providers with group therapy or structured visit schedules built into the program.
And if regulatory compliance matters to you before signing up, the February 2026 FDA warning letter is a real factor. The letter addressed misleading labeling on Belle’s website. Belle continues to operate, but for risk-averse buyers who need full transparency on compounding provenance, the record gives pause.
How Much Does Belle Health Cost?
Belle Health’s compounded semaglutide starts at $119 per month on a flat-rate pricing model, meaning the monthly cost remains fixed regardless of how the dose increases over the titration schedule.
No membership fees apply. Belle charges no recurring platform fee on top of medication cost. Named pharmacy partners handle fulfillment. Free overnight shipping is typically offered after provider approval. The out-of-pocket cost beyond $119 is minimal for most users.
Tirzepatide is available separately. As a reference point, Fridays offers tirzepatide at $240 per month with an annual prepay option. For users specifically seeking tirzepatide over semaglutide, that comparison is worth making before committing to Belle.
Is Belle Health Worth the Price?
Yes. Belle Health’s $119 per month for compounded semaglutide represents approximately a 90% savings compared to brand Ozempic, which retails for $900-$1,300 (USD) per month without insurance, making it one of the most cost-accessible GLP-1 programs available.
AllyRx awarded Belle 22 out of 25 on the pricing category. That’s one of its strongest individual scores in the evaluation. The flat-rate structure makes the cost predictable. No surprise increases as the dose goes up, which is a real differentiator in a category where pricing opacity is common.
To be clear: $119 per month covers provider review, pharmacy fulfillment, medication, and async care team access. No add-ons required. For buyers who want medication access without paying for coaching or live visits they won’t use, Belle’s value is straightforward.
How Does Belle Health Compare to Competitors?
Belle Health scores 84 out of 100 on AllyRx’s editorial rating, beating Fridays (80/100) and scoring competitively against Ro and Mochi Health in a head-to-head evaluation framework.
Provider comparison:
| Provider | AllyRx Score | Semaglutide Price/Mo | Live Coaching |
|---|---|---|---|
| Belle Health | 84/100 | $119 | No (async only) |
| Fridays | 80/100 | ~$150 (annual) | Yes (group) |
| Mochi Health | 4.11 user | Varies | Yes (coaching) |
| Ro | 4.00 user | Higher | Yes (provider visits) |
Belle beats Fridays on overall score (84 vs 80) and quality (17/20 vs 15/20). Fridays counters with more aggressive annual tirzepatide pricing at $240 per month and unlimited provider visits. Ro offers more structured provider visits but at a higher price point. Quality scores favor Ro, but Belle wins on cost and simplicity.
Mochi Health holds a 4.11 AllyRx user rating versus Belle’s 4.2. Both compete on price. Mochi is consistently noted for a stronger coaching component. Belle wins on accessibility. The right choice depends on whether the buyer prioritizes affordability or ongoing clinical engagement.
What Results Can You Expect?
Belle Medical’s clinical team reports patients losing 15-20% of body weight on semaglutide without physically demanding exercise, consistent with phase 3 clinical trial data showing 12-15% average weight reduction over 68 weeks of weekly semaglutide injections.
Significant results become more visible at 8-12 weeks. The good news? The first 1-4 weeks aren’t without progress. Appetite suppression kicks in quickly, and early weight loss of 2-5 lbs (0.9-2.3 kg) is typical in the first month. The bigger drops come later as titration escalates.
Long-term use requires continued administration for weight maintenance. Studies consistently show weight returns after stopping GLP-1 medications without sustained lifestyle changes. Belle Health’s publicly available materials don’t address post-medication maintenance planning directly. That’s worth keeping in mind before committing long-term.
What Happens in the First Month?
Most Belle Health users start at the lowest semaglutide dose, experience appetite suppression within the first few days, and encounter peak nausea in weeks 1-2 before symptoms typically ease as the body adjusts to the starting level.
Weeks 2-4 bring a reduction in nausea for most users. Appetite suppression continues. Weight loss accumulates. Most users lose 2-5 lbs (0.9-2.3 kg) in the first month. The exact amount depends on adherence, dietary choices, and individual metabolic response. Don’t measure success by week 2.
Dose escalation follows a standard semaglutide titration schedule. Belle’s care team is noted in Trustpilot reviews for allowing patient-guided pacing. If symptoms at the starting dose are significant, the team can delay escalation rather than forcing the standard timeline. That flexibility matters for tolerability.
How Do You Maximize Results?
A high-protein, lower-carbohydrate diet complements GLP-1 appetite suppression most effectively by preserving lean muscle mass during the caloric deficit that semaglutide creates, preventing the muscle loss that accompanies rapid weight reduction.
Tips to maximize results:
- Eat high-protein meals to preserve lean muscle during caloric deficit
- Add 2+ resistance training sessions per week to improve body composition
- Track weight weekly and report progress to the care team via messaging
- Request lab work at baseline and mid-treatment for metabolic monitoring
Resistance training delivers the greatest benefit for GLP-1 users. Belle’s program doesn’t require demanding exercise, but resistance work preserves lean mass and improves body composition beyond what weight loss alone achieves. Even two sessions per week produces measurable results during active medication use.
Regular tracking and care team communication support better outcomes. Belle’s async messaging channel lets users report progress and request dose adjustments. Lab work at baseline and mid-treatment helps catch any metabolic changes that need management before they become a problem.
Is Belle Health Worth It?
Belle Health earns an 84 out of 100 AllyRx editorial score and a 4.3 Trustpilot rating from 343 reviews, making it one of the better-rated budget-friendly telehealth GLP-1 providers for self-directed users who prioritize affordability over coaching depth.
The company is real. A registered Utah LLC with over 30,000 customers, an A+ BBB rating, and 8 years of operation. The February 2026 FDA warning letter for misleading labeling is a material fact worth knowing before you commit. Belle continues to operate with named pharmacy partners, but the compliance record belongs in any honest assessment of the service.
Short answer: Belle Health is best for buyers who want affordable compounded semaglutide, are comfortable with online-only care, and don’t need live coaching or maximum regulatory transparency. For that profile, few providers match the combination of price, ratings, and accessibility.
Who Should Look Elsewhere?
Buyers who want group coaching, structured accountability, or frequent live provider check-ins should consider Fridays or Mochi Health, both of which include coaching components that Belle’s async messaging model doesn’t replicate.
Risk-averse buyers face a real concern with Belle’s compliance record. The FDA warning letter from February 2026 flagged misleading labeling about who compounded the medications. The issue doesn’t disqualify Belle for every buyer. But for compliance-sensitive users, it’s a legitimate reason to look at providers with a cleaner regulatory history.
Users focused specifically on tirzepatide should compare pricing before committing. Fridays offers tirzepatide at $240 per month with an annual prepay option. For tirzepatide-priority buyers, Fridays’ pricing may undercut Belle’s equivalent offering. Run the numbers before deciding.